EUVIMEDEUVIMED entdecken
Crossref

Polyphenol‐Based Self‐Assembled Nanomedicine for a Three‐Pronged Approach to Reversing Tumor Immunosuppression

Zimu Li, Zirui Chen, Kexin Shi, Ping Huang, Wenfeng Zeng, Qili Huang, Jingwen Peng, Li Yang, Hongzhong Chen, Yanli Zhao iD, Xiaowei Zeng

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Zimu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Polyphenols, Nanomedicine, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: China Scholarship Council program, Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenges of multi‐pathway immune resistance and systemic toxicity caused by the direct injection of immune checkpoint inhibitors are critical factors that compromise the effectiveness of clinical immune checkpoint blockade therapy. In this context, natural polyphenols have been employed as the primary component to construct a targeted and acid‐responsive PD‐L1 antibody (αPD‐L1) delivery nanoplatform. This platform incorporates garcinol, an inhibitor of the Nuclear Factor Kappa‐B (NF‐κB) signaling pathway, to regulate pro‐tumor immune escape cytokines and regulatory T cells. Additionally, the nanoplatform has been verified to induce immunogenic cell death (ICD), which promotes the maturation of dendritic cells and enhances the activity of cytotoxic T lymphocytes. In vivo and in vitro experimental results demonstrated that the nanoplatform can boost the immune response through a PD‐L1 and NF‐κB blocking/ICD inducing three‐pronged strategy, thereby effectively combating tumor growth and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyphenolsNanomedicineNeoplasmsAnimalsMiceB7-H1 AntigenHumansNF-kappa BCell Line, TumorImmunogenic Cell DeathFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

NF‐κB inhibitordrug deliveryimmune checkpoint blockade therapyimmunotherapypolyphenol‐based nanomedicine

Substanzen

PolyphenolsB7-H1 AntigenNF-kappa B

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.
  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore.

ORCID-Profile: Yanli Zhao

Förderung

  • China Scholarship Council program
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, Z., Chen, Z., Shi, K., Huang, P., Zeng, W., Huang, Q., Peng, J., Yang, L., Chen, H., Zhao, Y., & Zeng, X. (2025). Polyphenol‐Based Self‐Assembled Nanomedicine for a Three‐Pronged Approach to Reversing Tumor Immunosuppression. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402127

Vancouver

Li Z, Chen Z, Shi K, Huang P, Zeng W, Huang Q, et al. Polyphenol‐Based Self‐Assembled Nanomedicine for a Three‐Pronged Approach to Reversing Tumor Immunosuppression. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402127

BibTeX
@article{Li2025,
  author = {Li, Zimu and Chen, Zirui and Shi, Kexin and Huang, Ping and Zeng, Wenfeng and Huang, Qili and Peng, Jingwen and Yang, Li and Chen, Hongzhong and Zhao, Yanli and Zeng, Xiaowei},
  title = {Polyphenol‐Based Self‐Assembled Nanomedicine for a Three‐Pronged Approach to Reversing Tumor Immunosuppression},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402127}
}
Kostenlos starten →